Sharabi Oz, Erijman Ariel, Shifman Julia M
Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Methods Enzymol. 2013;523:41-59. doi: 10.1016/B978-0-12-394292-0.00003-5.
Learning to control, protein-binding specificity is useful for both fundamental and applied biology. In fundamental research, better understanding of complicated signaling networks could be achieved through engineering of regulator proteins to bind to only a subset of their effector proteins. In applied research such as drug design, nonspecific binding remains a major reason for failure of many drug candidates. However, developing antibodies that simultaneously inhibit several disease-associated pathways are a rising trend in pharmaceutical industry. Binding specificity could be manipulated experimentally through various display technologies that allow us to select desired binders from a large pool of candidate protein sequences. We developed an alternative approach for controlling binding specificity based on computational protein design. We can enhance binding specificity of a protein by computationally optimizing its sequence for better interactions with one target and worse interaction with alternative target(s). Moreover, we can design multispecific proteins that simultaneously interact with a predefined set of proteins. Unlike combinatorial techniques, our computational methods for manipulating binding specificity are fast, low cost and in principle are able to consider an unlimited number of desired and undesired binding partners.
学会控制蛋白质结合特异性对基础生物学和应用生物学都很有用。在基础研究中,通过工程改造调节蛋白使其仅与效应蛋白的一个子集结合,可以更好地理解复杂的信号网络。在药物设计等应用研究中,非特异性结合仍然是许多候选药物失败的主要原因。然而,开发能同时抑制多种疾病相关途径的抗体在制药行业中呈上升趋势。可以通过各种展示技术对结合特异性进行实验性操控,这些技术使我们能够从大量候选蛋白质序列中筛选出所需的结合蛋白。我们基于计算蛋白质设计开发了一种控制结合特异性的替代方法。我们可以通过计算优化蛋白质序列,使其与一个靶标更好地相互作用,而与其他靶标相互作用更差,从而提高蛋白质的结合特异性。此外,我们可以设计同时与一组预定义蛋白质相互作用的多特异性蛋白质。与组合技术不同,我们用于操控结合特异性的计算方法速度快、成本低,原则上能够考虑无限数量的期望和不期望的结合伙伴。